mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.6 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |